Cargando…

A novel TPD52L2-ROS1 gene fusion expanding the molecular alterations in inflammatory myofibroblastic tumor: case report and literature review

BACKGROUND: Inflammatory myofibroblastic tumor (IMT) is a distinctive tumor composed of spindle cells accompanied by mixed inflammatory cells, and immunohistochemical positivity for ALK (anaplastic lymphoma kinase protein) can be detected in half of IMTs. The diagnosis of ALK-negative IMT could be a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Xuguang, Duan, Yaqi, Wang, Guoping, Zhu, Pengcheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10512592/ https://www.ncbi.nlm.nih.gov/pubmed/37735390 http://dx.doi.org/10.1186/s13000-023-01382-0

Ejemplares similares

TPD52L1-ROS1 Rearrangement as a New Acquired Resistance Mechanism to Osimertinib That Responds to Crizotinib in Combination With Osimertinib in Lung Adenocarcinoma
por: Xu, Caihua, et al.
Publicado: (2020)

TPD52L2 Is a Prognostic Biomarker and Correlated With Immune Infiltration in Lung Adenocarcinoma
por: Zhong, Anyuan, et al.
Publicado: (2021)

Tumor protein D52 (TPD52) affects cancer cell metabolism by negatively regulating AMPK
por: Chen, Yali, et al.
Publicado: (2022)

Decreased TPD52 expression is associated with poor prognosis in primary hepatocellular carcinoma
por: Wang, Ying, et al.
Publicado: (2015)

TPD36 - A test program for the TPD modules
por: Fagerstrom, J
Publicado: (1990)

The Antitumor Effect of TPD52L2 Silencing on Oxaliplatin-Resistant Gastric Carcinoma Is Related to Endoplasmic Reticulum Stress In Vitro
por: Zhang, Yu, et al.
Publicado: (2022)

Downregulation of MicroRNA-449 Promotes Migration and Invasion of Breast Cancer Cells by Targeting Tumor Protein D52 (TPD52)
por: Zhang, Zhiling, et al.
Publicado: (2017)

Cross talk of tumor protein D52 (TPD52) with KLF9, PKCε, and MicroRNA 223 in ovarian cancer
por: Khan, Khushbukhat, et al.
Publicado: (2023)

The TPD Calibration program
por: Strom, D, et al.
Publicado: (1987)

Anti-osteosarcoma effect of antiserum against cross antigen TPD52 between osteosarcoma and Trichinella spiralis
por: Yue, Tao-Tao, et al.
Publicado: (2021)

MiR-139-5p Inhibits the Development of Gastric Cancer through Targeting TPD52
por: Li, Yuanbo, et al.
Publicado: (2022)

MAL2 and tumor protein D52 (TPD52) are frequently overexpressed in ovarian carcinoma, but differentially associated with histological subtype and patient outcome
por: Byrne, Jennifer A, et al.
Publicado: (2010)

The four-transmembrane protein MAL2 and tumor protein D52 (TPD52) are highly expressed in colorectal cancer and correlated with poor prognosis
por: Li, Jingwen, et al.
Publicado: (2017)

Hsa_circ_0007637 Facilitates Nasopharyngeal Carcinoma Progression by Sponging miR-636/TPD52 Axis
por: Wang, Yihong, et al.
Publicado: (2021)

Retracted: MiR-139-5p Inhibits the Development of Gastric Cancer through Targeting TPD52
por: Engineering, Journal of Healthcare
Publicado: (2023)

Androgen receptor suppresses lung cancer invasion and increases cisplatin response via decreasing TPD52 expression
por: Liu, Shiqing, et al.
Publicado: (2023)

Tumor Protein D52 (TPD52) Inhibits Growth and Metastasis in Renal Cell Carcinoma Cells Through the PI3K/Akt Signaling Pathway
por: Zhao, Zhenhua, et al.
Publicado: (2017)

Hsa_circ_0084927 Regulates Cervical Cancer Advancement via Regulation of the miR-634/TPD52 Axis
por: Shi, Peijing, et al.
Publicado: (2020)

Exosomal Circ-XIAP Promotes Docetaxel Resistance in Prostate Cancer by Regulating miR-1182/TPD52 Axis
por: Zhang, Hui, et al.
Publicado: (2021)

Regulation of TPD52 by antitumor microRNA-218 suppresses cancer cell migration and invasion in lung squamous cell carcinoma
por: Kumamoto, Tomohiro, et al.
Publicado: (2016)

miR-139-5p regulates proliferation, apoptosis, and cell cycle of uterine leiomyoma cells by targeting TPD52
por: Chen, Hong, et al.
Publicado: (2016)

Identification of TPD52 and DNAJB1 as two novel bile biomarkers for cholangiocarcinoma by iTRAQ-based quantitative proteomics analysis
por: Ren, Hongyue, et al.
Publicado: (2019)

Tissue microarray profiling and integrative proteomics indicate the modulatory potential of Maytenus royleanus in inhibition of overexpressed TPD52 in prostate cancers
por: Shabbir, Maria, et al.
Publicado: (2021)

EMBR-21. CLINICALLY TRACTABLE OUTCOME PREDICTION OF GROUP 3/4 MEDULLOBLASTOMA BASED ON TPD52 IMMUNOHISTOCHEMISTRY: A MULTICOHORT STUDY
por: Delaidelli, Alberto, et al.
Publicado: (2021)

PATH-03. Clinically Tractable Outcome Prediction of Group 3/4 Medulloblastoma Based on TPD52 Immunohistochemistry: a Multicohort Study
por: Delaidelli, Alberto, et al.
Publicado: (2022)

miR-139-5p Regulates Proliferation, Apoptosis, and Cell Cycle of Uterine Leiomyoma Cells by Targeting TPD52 [Retraction]
Publicado: (2023)

Delayed recruiting of TPD52 to lipid droplets – evidence for a “second wave” of lipid droplet-associated proteins that respond to altered lipid storage induced by Brefeldin A treatment
por: Chen, Yuyan, et al.
Publicado: (2019)

miR-139-5p Regulates Proliferation, Apoptosis, and Cell Cycle of Uterine Leiomyoma Cells by Targeting TPD52 [Expression of Concern]
Publicado: (2020)

Microcystic Stromal Tumor of Testicle: First Case Report and Literature Review
por: Zhu, Pengcheng, et al.
Publicado: (2018)

TPD test programs Instructions on how to use them
por: Thomas, J
Publicado: (1987)

Long Non-Coding RNA HULC Promotes Cervical Cancer Cell Proliferation, Migration and Invasion via miR-218/TPD52 Axis
por: Lu, Wenjun, et al.
Publicado: (2020)

Investigation of Transcript Variant 6 of TPD52L2 as a Prognostic and Predictive Biomarker in Basal-Like MDA-MB-231 and MDA-MB-453 Cell Lines for Breast Cancer
por: Zhang, Xin, et al.
Publicado: (2022)

Draft Whole-Genome Sequences of Xylella fastidiosa subsp. fastidiosa Strains TPD3 and TPD4, Isolated from Grapevines in Hou-li, Taiwan
por: Castillo, Andreina I., et al.
Publicado: (2019)

Microwave ablation for the management of pulmonary inflammatory myofibroblastic tumor: a case report and literature review
por: Zhang, Yizhong, et al.
Publicado: (2021)

Long Noncoding RNA DSCAM-AS1 Facilitates Proliferation and Migration of Hemangioma Endothelial Cells by Targeting miR-411-5p/TPD52 Axis
por: Wang, Yulong, et al.
Publicado: (2022)

Knockdown of lncRNA PCAT6 Enhances Radiosensitivity in Triple-Negative Breast Cancer Cells by Regulating miR-185-5p/TPD52 Axis
por: Shi, Rui, et al.
Publicado: (2020)

Retracted: Long Noncoding RNA DSCAM-AS1 Facilitates Proliferation and Migration of Hemangioma Endothelial Cells by Targeting miR-411-5p/TPD52 Axis
por: International, BioMed Research
Publicado: (2023)

Nanostring-based screening for tyrosine kinase fusions in inflammatory myofibroblastic tumors
por: Kurihara, Taisei, et al.
Publicado: (2020)

A recurrent inflammatory myofibroblastic tumor patient with two novel ALK fusions: a case report
por: Xu, Xiumei, et al.
Publicado: (2022)

Beyond canonical PROTAC: biological targeted protein degradation (bioTPD)
por: Wang, Huifang, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_teah83nnqrp7sbl737m1i2rlqs